Cargando…
The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC)
A biosimilar is a biologic product that is similar to a reference biopharmaceutical product, the manufacturing process of which hinders the ability to identically replicate the structure of the original product, and therefore, it cannot be described as an absolute equivalent of the original medicati...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Associação Brasileira de Divulgação Científica
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769764/ https://www.ncbi.nlm.nih.gov/pubmed/29340530 http://dx.doi.org/10.1590/1414-431X20177214 |